First Time Loading...

Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 3 064 JPY -0.49% Market Closed
Updated: May 6, 2024

Rohto Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rohto Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
4911
4927
4452
F
4921
4967

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Revenue
¥263.6B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
7%
Shiseido Co Ltd
TSE:4911
Revenue
¥973B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Pola Orbis Holdings Inc
TSE:4927
Revenue
¥173.3B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Kao Corp
TSE:4452
Revenue
¥1.5T
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
F
Fancl Corp
TSE:4921
Revenue
¥108.1B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Revenue
¥173.5B
CAGR 3-Years
5%
CAGR 5-Years
1%
CAGR 10-Years
4%

See Also

What is Rohto Pharmaceutical Co Ltd's Revenue?
Revenue
263.6B JPY

Based on the financial report for Dec 31, 2023, Rohto Pharmaceutical Co Ltd's Revenue amounts to 263.6B JPY.

What is Rohto Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Rohto Pharmaceutical Co Ltd have been 14% over the past three years , 8% over the past five years , and 7% over the past ten years .